Research programme: Ras pathway modulators - MorphochemAlternative Names: MCP1; Ras pathway modulators research programme - Morphochem
Latest Information Update: 28 Jul 2010
At a glance
- Originator Fox Chase Cancer Center; Morphochem AG
- Class Small molecules
- Mechanism of Action Ras signal transduction pathway modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 28 Jul 2010 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 28 Jul 2010 Discontinued - Preclinical for Cancer in Germany (unspecified route)
- 01 Dec 2005 Morphochem AG has been acquired by Biovertis AG